FORMULATION AND EVALUATION OF KETOCONAZOLE NIOSOMAL GEL

Authors

  • Paninder Kaur Shivalik College of Pharmacy, Nangal, Punjab, India
  • J.S Dua Shivalik College of Pharmacy, Nangal, Punjab, India
  • D.N Prasad Shivalik College of Pharmacy, Nangal, Punjab, India

DOI:

https://doi.org/10.22270/ajprd.v6i5.424

Keywords:

Niosomes, NDDS, Ketoconazole, Cholesterol, Span 60/ Span 40

Abstract

ABSTRACT

 

In recent years, treatment of infectious disease through Novel Drug delivery system (NDDS) has undergone a revolutionary shift. Niosomes are a Novel Drug Delivery system which has potential application to treat infectious disease topically. Niosomes are non-ionic surfactant vesicles, in which medication is encapsulated in a vesicle for controlled drug release. Ketoconazole niosomes were prepared by using Cholesterol, Span 60/ Span 40 as surfactants, chloroform, and diethyl ether using rotary vacuum evaporator method. Formulation was then evaluated for particle size, drug content, entrapment efficiency, and in-vitro drug release studies. The Entrapment efficiency and drug content were calculated at 225nm using UV spectrophotometer. The drug content was found to be 70.37% for Span 40 and 72.81% for Span 60.The percentage of drug entrapment in niosomes was 60.3 % for Span 40 and 62.21 % for Span 60. FT-IR studies for niosomes containing Span 40 shows -CH stretching (Aliphatic) at 2891 cm-1and2925 cm-1 for niosomes containing Span 60. Ketoconazole niosomal gel was prepared using Carbopol 940, glycerol, Triethanolamine and distilled water. Evaluation of niosomal gel was determined by Physical appearance, pH, viscosity, drug content, entrapment efficiency and In-vitro diffusion studies.The percentage of the drug release from the niosomal gel was found to be 40.78 % for Span 40 and 33.75% for Span 60 . This delivery system is cost effective and simple to prepare as only the prepared gel of niosomes was introduced in Rotary vacuum evaporator for solvent evaporation.

 

 

Downloads

Download data is not yet available.

Author Biographies

Paninder Kaur, Shivalik College of Pharmacy, Nangal, Punjab, India

Department of Pharmaceutics, Shivalik College of Pharmacy, Naya Nangal, 140126, Punjab, India.

J.S Dua, Shivalik College of Pharmacy, Nangal, Punjab, India

Department of Pharmaceutics, Shivalik College of Pharmacy, Naya Nangal, 140126, Punjab, India.

D.N Prasad, Shivalik College of Pharmacy, Nangal, Punjab, India

Department of Pharmaceutics, Shivalik College of Pharmacy, Naya Nangal, 140126, Punjab, India

References

1. Ahmed M, SamyAfaf A, Ramadan Amal S.M, Abu El-Enin, Yasmin I.M Mortagi. Formulation and Optimization of Itraconazole Proniosomes using box behnken design. International Journal of applied Pharmaceutics. 2018; 10(2): 41-51.
2. Gurjar P, Naik N, Chouksey S. Niosome: A Promising Pharmaceutical Drug Delivery. International Journal of Pharmaceutics and Drug Analysis.2014; 2(5): 425-431.
3. Kumar A, Pal JL, Jaiswal A, Singh V. Review on Niosomes as Novel Drug Delivery System. International Research Journal of Pharmacy. 2011; 61-65.
4. Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Internatinal Journal Pharmaceutics. 2011;403: 245-253.
5. Sharma S.K, Chauhan M, Kumar A. Span-60 Niosomal Oral Suspension of Fluconazole: Formulation and In Vitro Evaluation. JPRHC. 2010; 142-156.
6. Saurabh B, Chandan PK, Geeta A and Harikumar SL. A comparative review on vesicular drug delivery system and stability issues.International Journal of research in pharmacy and chemistry. 2012; 2(3): 704- 713.
7. Balakrishan P et.al. Formulation and in-vitro assessment of Minoxidil niosomes for enhanced skin delivery. International Journal of Pharmaceutics. 2014; 377: 1-8.
8. Samyuktha Rani B, Vedha Hari BN. Niosomal formulation of Orlistat: Formulation and in-vitro evaluation. International Journal of Drug Development and Research. 2011; 3(3): 300-311.
9. Shirsand SB, Para MS, Nagendrakumar D, Kanani KM, Keerthy D. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig. 2012; 2(4): 201-107.
10. Vyas SP, Khar RK. Targeted and controlled drug delivery novel carrier systems. New delhi. Cbs publishers and distributors. 2004; 40: 3-13.
11. Anbarasan B, Rekha S, Elango K, Shriya B, Ramaprabhu S. Optimization of the formulation and in-vitro evaluation of capecitabine niosomes for the treatment of color cancer. IJPSR. 2013; 4(4): 504-1513.
12. Sabarikumar K, Varatharajan P, Sheema MS. Bioavailability enhancement of Aceclofenac niosomes containing surfactants and cholesterol. International Journal of Biological and Pharmaceutical Research. 2012; 3(3): 354-359.
13. Rajera R, Nagpal K, Kumar S, Mishra DN. Niosomes: A controlled and novel drug delivery system. Biol. Pharm Bull. 2011; 34(7): 945-953.

Published

2018-10-31

How to Cite

Kaur, P., Dua, J., & Prasad, D. (2018). FORMULATION AND EVALUATION OF KETOCONAZOLE NIOSOMAL GEL. Asian Journal of Pharmaceutical Research and Development, 6(5), 71–75. https://doi.org/10.22270/ajprd.v6i5.424